Purpose
To provide additional key insights into the impacts of measles containing vaccine (MCV) 10- to 5-dose vial switches on coverage, wastage and cost, and to engage in additional implementation research focused on maximizing switch impact.
Grantee
Division
Global Development
Date
DECEMBER 2024
Region served
AFRICA
Committed amount
$528,500
Grant topic
Vaccine Delivery
Duration (months)
13
Grantee location
Nairobi, 30, Kenya
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.